Scholar Rock submitted its BLA of apitegromab for the treatment of patients with Spinal Muscular Atrophy with a request for ...

A Tucson environmental group is suing the U.S. Food and Drug Administration for failing to set limits on PFAS, also known as ...

NIH has long overseen extraordinary achievements in biomedical knowledge that have been catalyzed by the NIH's traditional peer-review process ... of the "bugto-drug" timeline will not occur ...

Alnylam Pharmaceuticals , Inc. (NASDAQ:ALNY), a leader in RNA interference (RNAi) therapeutics, stands at a pivotal juncture as it seeks to capitalize on the burgeoning market for ...

A decline in R&D investment in neglected tropical diseases threatens progress toward critical targets. For over 20 years, one ...

In this month’s wind-driven wildfires in Southern California, evacuation alerts for some neighborhoods came long after homes ...

OTTAWA — Foreign Affairs Minister Mélanie Joly said Monday the federal government is preparing for the 2026 review of the ...

The Trump administration has pressed the pause button on the U.S.’s vital biomedical research engine, the National Institutes for Health. Grant reviews, travel and hiring appear to be on indefinite ...

Scholar Rock , a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy (SMA), cardiometabolic disorders, and other serious diseases where protein ...

ORLANDO, FL - NutriBand Inc. (NASDAQ:NTRB), a developer of transdermal pharmaceutical products with a current market capitalization of $80 million, announced the results of its Annual Meeting of ...

Elizabeth Rose Struhs died on January 7, 2022 while lying on a mattress on the floor of her family’s Toowoomba home, west of ...

The Trump administration has pressed the pause button on the U.S.’s vital biomedical research engine, the National Institutes ...